Pegaptanib sodium (Macugen)

pegaptanib sodium · Eyetech Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pegaptanib sodium (Macugen), covering 2007-01-15 to 2011-05-04. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration [Phase 2]